+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Transfer Membrane Market Size, Share & Industry Trends Analysis Report by Product, Application, End-User, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 99 Pages
  • March 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5779135
The Europe Transfer Membrane Market should witness market growth of 4.0% CAGR during the forecast period (2022-2028).

Dry electroblotting techniques use a unique transfer sandwich with cutting-edge components that do not need conventional transfer buffers. Instead of buffer tanks or soaked filter papers, a unique gel matrix (transfer stack) with buffer is used. Rapid protein transfer is made possible by the gel matrix's high ionic density. Blot distortion is decreased because water electrolysis at the copper anode does not produce oxygen gas during blotting. Wet and semi-dry protein transfer methods use inert electrodes with oxygen.

Often, closer spacing between electrodes, a strong field, and a high current help speed up the transmission. Setup and cleaning times are considerably reduced compared to other transfer techniques since buffers don't need to be created. The thermal motion of molecules, which causes them to flow from a region of high concentration to an area of low concentration, is the basis for diffusion blotting.

The French government and pharmaceutical sector have committed to taking all necessary steps to raise medical R&D investment by 10% over the next three years. According to the French government, the new goal is to make France's pharmaceutical sector competitive in terms of R&D spending. Furthermore, various measures are already in place to encourage businesses to boost investment. Included are newly increased tax benefits for companies making R&D investments and separate tax relief for the pharmaceutical sector. The government's involvement in surging R&D in the pharmaceutical sector is expected to propel the transfer membrane market growth in the region.

The Germany market dominated the Europe Transfer Membrane Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $28,375.4 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 3.2% during (2022-2028). Additionally, The France market would exhibit a CAGR of 4.8% during (2022-2028).

Based on Product, the market is segmented into PVDF, Nitrocellulose and Nylon. Based on Transfer Method, the market is segmented into Dry Electro Blotting (Dry Transfer), Semi-dry Electro Blotting (Semi-dry Transfer), Wet or Tank Transfer and Others. Based on Application, the market is segmented into Western Blotting, Southern Blotting, Northern Blotting and Others. Based on End-User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes and Diagnostic Labs. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer, Inc., Abcam Plc, Santa Cruz Biotechnology, Inc., ATTO Corporation, Azure Biosystems, Inc., and GVS S.p. A.

Scope of the Study

By Product

  • PVDF
  • Nitrocellulose
  • Nylon

By Transfer Method

  • Dry Electro Blotting (Dry Transfer)
  • Semi-dry Electro Blotting (Semi-dry Transfer)
  • Wet or Tank Transfer
  • Others

By Application

  • Western Blotting
  • Southern Blotting
  • Northern Blotting
  • Others

By End-User

  • Biopharmaceutical & Pharmaceutical Companies
  • Academic & Research Institutes
  • Diagnostic Labs

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Abcam Plc
  • Santa Cruz Biotechnology, Inc.
  • ATTO Corporation
  • Azure Biosystems, Inc.
  • GVS S.p. A

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Transfer Membrane Market, by Product
1.4.2 Europe Transfer Membrane Market, by Transfer Method
1.4.3 Europe Transfer Membrane Market, by Application
1.4.4 Europe Transfer Membrane Market, by End-User
1.4.5 Europe Transfer Membrane Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Transfer Membrane Market
Chapter 4. Europe Transfer Membrane Market by Product
4.1 Europe PVDF Market by Country
4.2 Europe Nitrocellulose Market by Country
4.3 Europe Nylon Market by Country
Chapter 5. Europe Transfer Membrane Market by Transfer Method
5.1 Europe Dry Electro Blotting (Dry Transfer) Market by Country
5.2 Europe Semi-dry Electro Blotting (Semi-dry Transfer) Market by Country
5.3 Europe Wet or Tank Transfer Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Transfer Membrane Market by Application
6.1 Europe Western Blotting Market by Country
6.2 Europe Southern Blotting Market by Country
6.3 Europe Northern Blotting Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Transfer Membrane Market by End-User
7.1 Europe Biopharmaceutical & Pharmaceutical Companies Market by Country
7.2 Europe Academic & Research Institutes Market by Country
7.3 Europe Diagnostic Labs Market by Country
Chapter 8. Europe Transfer Membrane Market by Country
8.1 Germany Transfer Membrane Market
8.1.1 Germany Transfer Membrane Market by Product
8.1.2 Germany Transfer Membrane Market by Transfer Method
8.1.3 Germany Transfer Membrane Market by Application
8.1.4 Germany Transfer Membrane Market by End-User
8.2 UK Transfer Membrane Market
8.2.1 UK Transfer Membrane Market by Product
8.2.2 UK Transfer Membrane Market by Transfer Method
8.2.3 UK Transfer Membrane Market by Application
8.2.4 UK Transfer Membrane Market by End-User
8.3 France Transfer Membrane Market
8.3.1 France Transfer Membrane Market by Product
8.3.2 France Transfer Membrane Market by Transfer Method
8.3.3 France Transfer Membrane Market by Application
8.3.4 France Transfer Membrane Market by End-User
8.4 Russia Transfer Membrane Market
8.4.1 Russia Transfer Membrane Market by Product
8.4.2 Russia Transfer Membrane Market by Transfer Method
8.4.3 Russia Transfer Membrane Market by Application
8.4.4 Russia Transfer Membrane Market by End-User
8.5 Spain Transfer Membrane Market
8.5.1 Spain Transfer Membrane Market by Product
8.5.2 Spain Transfer Membrane Market by Transfer Method
8.5.3 Spain Transfer Membrane Market by Application
8.5.4 Spain Transfer Membrane Market by End-User
8.6 Italy Transfer Membrane Market
8.6.1 Italy Transfer Membrane Market by Product
8.6.2 Italy Transfer Membrane Market by Transfer Method
8.6.3 Italy Transfer Membrane Market by Application
8.6.4 Italy Transfer Membrane Market by End-User
8.7 Rest of Europe Transfer Membrane Market
8.7.1 Rest of Europe Transfer Membrane Market by Product
8.7.2 Rest of Europe Transfer Membrane Market by Transfer Method
8.7.3 Rest of Europe Transfer Membrane Market by Application
8.7.4 Rest of Europe Transfer Membrane Market by End-User
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent Strategies and Developments
9.1.5.1 Product Launches and Product Expansions
9.1.5.2 Acquisition and Mergers
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent Strategies and Developments
9.2.5.1 Acquisition and Mergers
9.3 Bio-Rad laboratories, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent Strategies and Developments
9.3.5.1 Acquisition and Mergers
9.4 Merck KGaA
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent Strategies and Developments
9.4.5.1 Geographical Expansion
9.5 PerkinElmer, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent Strategies and Developments
9.5.5.1 Acquisition and Mergers
9.6 Abcam Plc
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.7 Santa Cruz Biotechnology, Inc.
9.7.1 Company Overview
9.8 ATTO Corporation
9.8.1 Company Overview
9.9 Azure Biosystems, Inc.
9.9.1 Company Overview
9.10. GVS S.p.A
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Abcam Plc
  • Santa Cruz Biotechnology, Inc.
  • ATTO Corporation
  • Azure Biosystems, Inc.
  • GVS S.p.A

Methodology

Loading
LOADING...